title: Novel pathways and molecular targets for the treatment of sarcoma.
abstract: Sarcomas collectively represent over 100 different subtypes of bone and soft tissue tumors of mesenchymal origin. The low response rate to cytotoxic chemotherapies has necessitated the need for development of either histologically driven or pathway-specific targeted therapies. As our understanding of the molecular mechanisms driving certain subtypes is rapidly advancing, the number of targeted therapies is also increasing. Recently identified novel druggable targets include the MDM2 amplifications in well-differentiated and dedifferentiated liposarcomas, the new translocation NAB2:STAT6 of solitary fibrous tumors, the angiopoeitin-TIE2 pathway in angiosarcoma, the suppression of Mcl1 in X:18/synovial sarcomas, the mTOR pathway in malignant peripheral nerve sheath tumors, CDK4 in alveolar rhabdomyosarcoma, cMET regulation in alveolar soft parts sarcoma, the metabolic abnormalities in wild-type/SHD GIST, and the lack of argininosuccinate synthetase 1 expression seen in most sarcomas. It is through a fundamental understanding of sarcoma biology that clinical trials based on molecular targets can be developed.
authors: Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA. afrith@dom.wustl.edu
authors: Ashley E
authors: AE
authors: Frith
authors: Angela C
authors: AC
authors: Hirbe
authors: Brian A
authors: BA
authors: Van Tine
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents
references: Curr Opin Oncol. 2012 Jul;24(4):425-30
references: 22572725
references: J Intern Med. 2009 Jul;266(1):43-52
references: 19522824
references: Cancer Res. 2007 Feb 1;67(3):919-29
references: 17283122
references: Cell Cycle. 2008 Jun 1;7(11):1604-12
references: 18520179
references: Science. 1998 Jan 23;279(5350):577-80
references: 9438854
references: J Clin Oncol. 2008 Nov 10;26(32):5269-74
references: 18809609
references: Cancer Cell. 2007 Apr;11(4):375-88
references: 17418413
references: Oncogene. 2003 Nov 6;22(50):8156-67
references: 14603256
references: Immunol Res. 2011 May;50(1):87-96
references: 21442426
references: Oncogene. 1996 Aug 1;13(3):643-8
references: 8760306
references: Am J Med Genet. 2002 Mar 1;108(2):132-9
references: 11857563
references: Pediatr Blood Cancer. 2013 Aug;60(8):1267-73
references: 23418028
references: Oncogene. 2013 Jan 31;32(5):651-62
references: 22710712
references: Lancet Oncol. 2012 Nov;13(11):1133-40
references: 23084521
references: Cancer Res. 2009 Sep 15;69(18):7175-9
references: 19723655
references: Clin Transl Oncol. 2012 Mar;14(3):197-206
references: 22374423
references: Eur J Cancer. 2003 Sep;39(14):2006-11
references: 12957454
references: Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8573-8
references: 15937108
references: Histopathology. 1995 Mar;26(3):279-81
references: 7541016
references: Mol Cancer Ther. 2010 Oct;9(10):2641-51
references: 20937592
references: Mol Cancer Ther. 2010 May;9(5):1286-97
references: 20457621
references: Skelet Muscle. 2012 Dec 03;2(1):25
references: 23206814
references: Am J Pathol. 1996 Feb;148(2):601-9
references: 8579122
references: Oncotarget. 2012 Mar;3(3):228-35
references: 22410433
references: Genes Dev. 2004 Aug 15;18(16):1926-45
references: 15314020
references: Oncogene. 1996 Feb 1;12(3):507-13
references: 8637706
references: J Pathol. 2000 Apr;190(5):531-6
references: 10727978
references: Sarcoma. 2012;2012:690251
references: 22566753
references: Nat Genet. 2013 Feb;45(2):180-5
references: 23313952
references: Ann Surg Oncol. 2007 Jun;14(6):1953-67
references: 17356953
references: Cancer Cell. 2004 Nov;6(5):507-16
references: 15542434
references: Sarcoma. 2011;2011:160369
references: 21647357
references: Trends Mol Med. 2007 Jan;13(1):23-31
references: 17126603
references: Br J Dermatol. 2010 Jul;163(1):225-7
references: 20394623
references: Hum Pathol. 1986 Oct;17(10):996-1008
references: 2428727
references: Hum Pathol. 1996 Oct;27(10):1060-5
references: 8892591
references: Oncology. 2011;80(1-2):50-6
references: 21625179
references: Clin Cancer Res. 2012 Jan 15;18(2):568-76
references: 22090362
references: Eur J Cancer. 2005 Dec;41(18):2853-60
references: 16289617
references: J Pathol. 2013 Jan;229(2):286-97
references: 23132749
references: Blood. 2010 Apr 22;115(16):3304-13
references: 20197552
references: Cancer Res. 2006 Mar 15;66(6):3169-76
references: 16540668
references: J Clin Oncol. 2002 Jun 1;20(11):2672-9
references: 12039929
references: J Biol Chem. 2006 Nov 3;281(44):33036-44
references: 16905769
references: Cancer. 1996 Jun 1;77(11):2400-6
references: 8635113
references: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3933-8
references: 18316739
references: Am J Pathol. 2000 Jun;156(6):2179-83
references: 10854238
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Cancer J. 2005 May-Jun;11(3):241-7
references: 16053668
references: Virchows Arch. 2010 Mar;456(3):277-85
references: 20039060
references: Neuro Oncol. 2013 Feb;15(2):135-47
references: 23161774
references: PLoS One. 2013;8(2):e58193
references: 23469153
references: Sarcoma. 2011;2011:483154
references: 21253554
references: Hum Mol Genet. 1999 Apr;8(4):585-91
references: 10072425
references: Adv Anat Pathol. 2006 Nov;13(6):279-85
references: 17075293
references: Curr Opin Oncol. 2009 Jul;21(4):327-31
references: 19444101
references: Oncogene. 2001 Jan 4;20(1):48-57
references: 11244503
references: Lancet Oncol. 2010 Oct;11(10):983-91
references: 20537949
references: J Clin Oncol. 2004 Sep 15;22(18):3813-25
references: 15365079
references: Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8
references: 21173220
references: Cancer. 2007 Aug 1;110(3):648-51
references: 17582627
references: Nat Rev Cancer. 2010 Aug;10(8):575-85
references: 20651738
references: Ann Oncol. 2013 Jan;24(1):257-63
references: 22910841
references: Mol Cancer Ther. 2010 Mar;9(3):535-44
references: 20159990
references: Cancer Metastasis Rev. 2007 Jun;26(2):341-52
references: 17415529
references: Cancer. 2008 Aug 1;113(3):616-27
references: 18618615
references: Clin Cancer Res. 2009 Feb 1;15(3):1096-104
references: 19188185
references: Am J Surg Pathol. 2013 Feb;37(2):234-40
references: 23282968
references: Mol Cancer Ther. 2010 Mar;9(3):545-57
references: 20179162
references: Genes Chromosomes Cancer. 1999 Jan;24(1):30-41
references: 9892106
references: Hum Mol Genet. 2005 Aug 1;14(15):2231-9
references: 15987702
references: Genes Chromosomes Cancer. 2009 Oct;48(10):886-96
references: 19585585
references: Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11788-93
references: 22745160
references: Cancer Cell. 2012 Mar 20;21(3):333-47
references: 22439931
references: Cancer Res. 2007 Jun 15;67(12):5840-50
references: 17575152
references: Hum Mol Genet. 2005 Nov 1;14(21):3263-9
references: 16195397
references: Anticancer Drugs. 2012 Feb;23(2):173-84
references: 22027537
references: J Med Chem. 2005 Jul 14;48(14):4491-9
references: 15999986